Fullerene inhibits beta-amyloid peptide aggregation (Q44378393)

2 December 2017

Fullerene inhibits beta-amyloid peptide aggregation (English)

1 reference

2 December 2017

1 reference

Jeong Eun Kim

1

1 reference

PubMed ID

12659858

2 December 2017

Minyung Lee

series ordinal

2

1 reference

PubMed ID

12659858

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Biochemical and Biophysical Research Communications

2 December 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 December 2017

303

1 reference

2 December 2017

2

1 reference

2 December 2017

576-579

1 reference

Alzheimer's disease: the amyloid cascade hypothesis

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Structural and functional imaging with carbon nanotube AFM probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

A molecular model of Alzheimer amyloid beta-peptide fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Alzheimer's disease: molecular concepts and therapeutic targets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

New Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Carboxyfullerenes as neuroprotective agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

3-p-Toluoyl-2-[4'-(3-diethylaminopropoxy)-phenyl]-benzofuran and 2-[4'-(3-diethylaminopropoxy)-phenyl]-benzofuran do not act as surfactants or micelles when inhibiting the aggregation of beta-amyloid peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900393-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-291X(03)00393-0

1 reference

2 December 2017

1 reference

PubMed ID

12659858